Get the Stockscreener App
4.36
11.79%
0.46
Neuronetics Inc stock is traded at $4.36, with a volume of 3.03M.
It is up +11.79% in the last 24 hours and up +101.85% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$3.90
Open:
$4.04
24h Volume:
3.03M
Relative Volume:
2.90
Market Cap:
$277.52M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-3.6949
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
+42.02%
1M Performance:
+101.85%
6M Performance:
+425.36%
1Y Performance:
+25.29%
1-Day Range:
$3.97
$4.57
1-Week Range:
$3.10
$4.57
52-Week Range:
$0.52
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.36 | 277.52M | 69.23M | -33.10M | -39.26M | -1.18 |
|
TMO
Thermo Fisher Scientific Inc
|
531.85 | 203.43B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.30 | 148.35B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
134.67 | 38.42B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
444.53 | 36.40B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
193.44 | 34.06B | 15.41B | 1.37B | 2.11B | 7.50 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics CFO Stephen Furlong sells $41,536 in stock - MSN
Savara Inc. Awards Stock Options and RSUs to New Employees - MyChesCo
Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of Stock - MarketBeat
Neuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in Stock - MarketBeat
Neuronetics EVP William Andrew Macan sells $46,630 in stock - MSN
Neuronetics Executives Sell Shares for Tax Obligations - TradingView
Neuronetics CFO Stephen Furlong sells shares worth $48,662 - MSN
Neuronetics CEO Keith Sullivan sells $134,453 in stock - MSN
Stephen Furlong Sells 14,836 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock - MarketBeat
Insider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 40,992 Shares of Stock - MarketBeat
Neuronetics' EVP William Andrew Macan sells $6,461 in stock - MSN
Neuronetics’ EVP William Andrew Macan sells $6,461 in stock By Investing.com - Investing.com Nigeria
Neuronetics CEO Keith Sullivan sells $134,453 in stock By Investing.com - Investing.com Australia
Neuronetics' EVP William Andrew Macan sells $6,461 in stock By Investing.com - Investing.com Canada
Transcranial Magnetic Stimulator Market Booming Demand, - openPR
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share - MSN
Neuronetics announces inducement grant - Medical Buyer
STIM’s Debt-to-Equity Ratio at 5.19: What It Means for Neuronetics Inc’s Future - The InvestChronicle
Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex
A year in review: Neuronetics Inc (STIM)’s performance in the last year - US Post News
Neuronetics Inc [STIM] Stock sold by Insider Furlong Stephen for $1122.0 - Knox Daily
Industry Analysts Just Made A Dazzling Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) Revenue Forecasts - Simply Wall St
Neuronetics Inc (STIM) Stock: A Closer Look at the Analyst Ratings - The News Heater
Neuronetics announces public stock offering - MSN
Neuronetics Announces Stock Awards to New Employees - MSN
Neuronetics shares drop as it prices $18M public offering of common stock - MSN
Neuronetics shares fall on launch of public offering of common stock - MSN
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Strategic Talent Acquisition: Inside the 15,750 Share RSU Package - StockTitan
Neuronetics Shares Drop After $18M Offering Priced - MarketWatch
Neuronetics Prices Eight Million Share Offering at $2.25 Per Share -February 07, 2025 at 08:19 am EST - Marketscreener.com
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock - EIN News
Neuronetics announces public stock offering By Investing.com - Investing.com Canada
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - The Manila Times
Are Smart Investors Making the Right Decision? Neuronetics Inc (STIM) - SETE News
Medical Transcranial Magnetic Stimulator Market Generated - openPR
Neuronetics Inc (STIM)’s stock chart: A technical perspective - US Post News
Market Momentum Report: Neuronetics Inc (STIM)’s Positive Close at 3.45 - The Dwinnex
Neuronetics Inc (STIM) rating downgrades by William Blair - Knox Daily
Unlocking the Healthcare Boom: Why Neuronetics is a Game-Changer for Investors - Jomfruland.net
Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Insider Monkey
Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Drops By 35.8% - MarketBeat
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):